What are MDT's business segments?

Medtronic plc (MDT) reports revenue by product line and geographic region in its 10-K segment disclosures. The composition lists on this page show the most recent breakdown; the expanded table view shows the multi-year transposed history.

Which segment generates the most revenue for MDT?

Medtronic plc's largest reported segment is Cardiac and Vascular Group, at $13.98 billion in revenue for fiscal year 2026 (ended April 24, 2026). It sits at the top of the composition list on this page. Segment mix can shift materially year over year, especially after acquisitions, divestitures, or new-product launches — the expand-modal view shows the full trajectory.

How current is MDT's segment data?

Medtronic plc (MDT)'s segment breakdown on this page is from its most recent annual filing, fiscal year 2026 (ended April 24, 2026). Segment disclosures are reported annually in the 10-K and refresh within 48 hours of each filing.

MDT

Medtronic plc

NYSE·Medical, Devices · Healthcare

$82.35$0.94−1.13%

After hours·$82.06−0.35%

Market cap$105.41B·Market closed·Jul 21 8:00 PM UTC

Frequently Asked Questions About MDT

What are MDT's business segments?: Medtronic plc (MDT) reports revenue by product line and geographic region in its 10-K segment disclosures. The composition lists on this page show the most recent breakdown; the expanded table view shows the multi-year transposed history.
Which segment generates the most revenue for MDT?: Medtronic plc's largest reported segment is Cardiac and Vascular Group, at $13.98 billion in revenue for fiscal year 2026 (ended April 24, 2026). It sits at the top of the composition list on this page. Segment mix can shift materially year over year, especially after acquisitions, divestitures, or new-product launches — the expand-modal view shows the full trajectory.
How current is MDT's segment data?: Medtronic plc (MDT)'s segment breakdown on this page is from its most recent annual filing, fiscal year 2026 (ended April 24, 2026). Segment disclosures are reported annually in the 10-K and refresh within 48 hours of each filing.

MDT

Medtronic plc

NYSE·Medical, Devices · Healthcare

$82.35$0.94−1.13%

After hours·$82.06−0.35%

Market cap$105.41B·Market closed·Jul 21 8:00 PM UTC

By Product

Latest period2026

Segment	Revenue	Share	YoY Growth %
Cardiac and Vascular Group	$13.98B	38.6%	+12.0%
Neuroscience Group	$10.29B	28.4%	+4.5%
Medical Surgical	$8.82B	24.4%	+4.9%
Diabetes Group	$3.11B	8.6%	+13.0%

By Geography

Latest period2026

Segment	Revenue	Share	YoY Growth %
UNITED STATES	$71.40B	79.6%	+315.8%
Total Other Countries, Excluding United States and Ireland	$18.12B	20.2%	+11.5%
IRELAND	$143.00M	0.2%	+23.3%

Frequently Asked Questions About MDT

What are MDT's business segments?: Medtronic plc (MDT) reports revenue by product line and geographic region in its 10-K segment disclosures. The composition lists on this page show the most recent breakdown; the expanded table view shows the multi-year transposed history.
Which segment generates the most revenue for MDT?: Medtronic plc's largest reported segment is Cardiac and Vascular Group, at $13.98 billion in revenue for fiscal year 2026 (ended April 24, 2026). It sits at the top of the composition list on this page. Segment mix can shift materially year over year, especially after acquisitions, divestitures, or new-product launches — the expand-modal view shows the full trajectory.
How current is MDT's segment data?: Medtronic plc (MDT)'s segment breakdown on this page is from its most recent annual filing, fiscal year 2026 (ended April 24, 2026). Segment disclosures are reported annually in the 10-K and refresh within 48 hours of each filing.